WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their ATHE stock forecasts and price targets.

Forecast return on equity

Is ATHE forecast to generate an efficient return?
Company
-4,946.51%
Industry
22.3%
Market
49.89%
ATHE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ATHE forecast to generate an efficient return on assets?
Company
-3,928.03%
Industry
9.42%
ATHE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ATHE earnings per share forecast

What is ATHE's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.13

ATHE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHE$1.26N/AN/A
PPBT$0.41$8.00+1,860.78%Buy
ADXN$10.54$30.00+184.58%Buy
BCTX$0.62$18.00+2,803.23%Buy
MBIO$0.28$2.00+614.29%Buy
View Top Biotech Stocks

Alterity Therapeutics Stock Forecast FAQ

What is ATHE's earnings growth forecast for 2025-2025?

(NASDAQ: ATHE) Alterity Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 29.48%.

Alterity Therapeutics's earnings in 2024 is -$8,027,294.

In 2025, ATHE is forecast to generate -$569,758,116 in earnings, with the lowest earnings forecast at -$569,758,116 and the highest earnings forecast at -$569,758,116.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is ATHE's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: ATHE) forecast ROE is -4,946.51%, which is considered weak.

What is ATHE's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ATHE) Alterity Therapeutics's current Earnings Per Share (EPS) is -$2.24. In 2025, ATHE's EPS is forecast to hit -$0.13 (min: -$0.13, max: -$0.13).

What is ATHE's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: ATHE) forecast ROA is -3,928.03%, which is lower than the forecast US Biotechnology industry average of 9.42%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.